Understanding Your Brain Tumour: Advanced Genetic Testing for Glioma
Receiving a glioma diagnosis can feel overwhelming, but understanding your tumour’s genetic makeup provides the clarity needed to navigate your treatment journey with confidence. Our comprehensive Glioma Panel test offers precise genetic analysis that helps determine the most effective treatment approach for your specific condition.
What This Test Reveals About Your Glioma
This advanced genetic panel examines three critical markers that significantly impact treatment decisions and prognosis:
- MGMT Status: Determines whether your tumour may respond better to certain chemotherapy treatments
- IDH1 & IDH2 Mutations: Identifies specific genetic changes that influence tumour behaviour and treatment options
- 1p19q Chromosomal Analysis: Assesses chromosomal changes that help classify your glioma type
Using sophisticated MLPA, FISH, and Sanger Sequencing methods, we provide detailed insights that guide personalised treatment strategies.
Who Should Consider This Genetic Testing?
This test is particularly valuable if you:
- Have been diagnosed with a glioma or suspected brain tumour
- Are experiencing symptoms like persistent headaches, seizures, or neurological changes
- Need clarity on treatment options and prognosis
- Want to understand if targeted therapies might be effective for your condition
- Seek confirmation of your glioma subtype for personalised care planning
Why Genetic Testing Matters for Your Brain Health
Understanding your glioma’s genetic profile provides several crucial benefits:
- Personalised Treatment Planning: Identifies which therapies are most likely to be effective
- Improved Prognostic Information: Helps predict how your tumour may behave over time
- Reduced Treatment Side Effects: Avoids ineffective treatments and their associated risks
- Peace of Mind: Provides clarity during a challenging diagnostic journey
- Informed Decision Making: Empowers you and your healthcare team with precise information
Understanding Your Test Results
Our comprehensive report provides clear, understandable results that your medical team can use immediately:
- MGMT Methylation Status: Indicates potential response to temozolomide chemotherapy
- IDH Mutation Profile: Helps classify glioma type and guide treatment selection
- 1p19q Codeletion Status: Distinguishes between oligodendroglioma and astrocytoma types
- Clinical Interpretation: Clear explanations of what each result means for your care
Our genetic counsellors are available to help you understand your results and their implications.
Investment in Your Health Journey
| Test Option | Price | Savings |
|---|---|---|
| Regular Price | ZAR 16,000 | – |
| Special Offer | ZAR 12,000 | ZAR 4,000 Savings |
Note: A doctor’s prescription is required for this test. Prescription requirements do not apply for surgical cases, pregnancy-related testing, or international travel purposes.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Analysis: Conducted by experienced genetic specialists using advanced technology
- Rapid Turnaround: Results typically available within 2-3 weeks
- Sample Requirements: Paraffin-embedded tumour tissue blocks
- Quality Assurance: Multiple validation methods ensure accuracy and reliability
Take Control of Your Brain Health Journey
Don’t let uncertainty about your glioma diagnosis create unnecessary anxiety. Our comprehensive genetic testing provides the clarity you need to make informed decisions about your treatment.
Book your Glioma Panel test today and receive your special ZAR 12,000 pricing. Early genetic analysis can significantly impact your treatment success and quality of life.
Contact us now to schedule your test or speak with our genetic counselling team about how this testing can benefit your specific situation.
